Tenaya Therapeutics (TNYA) Change in Cash (2020 - 2026)

Tenaya Therapeutics' Change in Cash history runs 7 years deep, the most recent figure standing at -$19.7 million for Q1 2026.

• In Q1 2026, Change in Cash fell 139.76% year-over-year to -$19.7 million; the TTM figure through Mar 2026 stood at $27.1 million (up 567.98% YoY), while the FY2025 annual figure was $96.2 million, up 331.19% from the prior year.
• Change in Cash for Q1 2026 stood at -$19.7 million, down from $44.2 million in the prior quarter.
• The five-year high for Change in Cash was $60.8 million in Q4 2022, with the low at -$49.9 million in Q3 2024.
• The 5-year median for Change in Cash is $3.0 million (2023), against an average of $2.5 million.
• The sharpest annual moves came in 2022 and 2025: Change in Cash tumbled 12587.63% in 2022, then jumped 1231.91% in 2025.
• Tenaya Therapeutics' Change in Cash stood at $60.8 million in 2022, then slumped by 160.01% to -$36.5 million in 2023, then jumped by 89.28% to -$3.9 million in 2024, then surged by 1231.91% to $44.2 million in 2025, then tumbled by 144.44% to -$19.7 million in 2026.
• Business Quant data shows TNYA's Change in Cash at -$19.7 million in Q1 2026, $44.2 million in Q4 2025, and -$6.4 million in Q3 2025.